Skip to main content
Frontiers in Oncology logoLink to Frontiers in Oncology
. 2023 Oct 4;13:1302993. doi: 10.3389/fonc.2023.1302993

Corrigendum: Evaluation of the Stellae-123 prognostic gene expression signature in acute myeloid leukemia

Adrián Mosquera Orgueira 1,*,, Andrés Peleteiro Raíndo 1,, José Ángel Díaz Arias 1, Beatriz Antelo Rodríguez 1, Mónica López Riñón 2, Claudio Cerchione 3, Adolfo de la Fuente Burguera 4, Marta Sonia González Pérez 1, Giovanni Martinelli 3, Pau Montesinos Fernández 5, Manuel Mateo Pérez Encinas 1
PMCID: PMC10583554  PMID: 37860185

In the published article, there was an error in affiliations 3 and 4. Instead of “3Department of Hematology, MD Anderson Cancer Center, Madrid, Spain, 4Unit of Hematology, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori Istituto Tumori della Romagna IRST IRCCS, Meldola, Italy”, it should be “3Unit of Hematology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, 4Department of Hematology, MD Anderson Cancer Center, Madrid, Spain”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Oncology are provided here courtesy of Frontiers Media SA

RESOURCES